Skip to main content
main content, press tab to continue
Webcast

Future-proofing your life science business

January 10, 2022

Our latest webinar looked at the trends shaping the future of life science businesses. The panellists discussed how to navigate the changing risk landscape and take advantage of the exciting opportunities that lay ahead.
Direct and Facultative
N/A

The last 18 months has been a rollercoaster ride for the life science sector.

The pandemic has been hugely disruptive to supply chains and caused many clinical trials to be postponed or cancelled.

But it has also opened new fast-track pathways for potentially life-changing treatments and accelerated the trend towards digitalisation of healthcare.

To help you navigate this fast-changing landscape, we have created a series of webinars with insights from risk management specialists and insurance experts on everything from preparing for the future, helping you manage risk, building resilience into your supply chain, and ensuring that your insurance program reflects the changes.

To help you navigate this fast-changing landscape, we have created a series of webinars with insights from risk management specialists and insurance experts.”

John Connolly | Life Sciences Industry Leader – North America,
Willis Towers Watson

Our first webinar took place on 2 December 2021, looking at future-proofing your life science business.

About the webinar

The life science sector is being transformed. Technology is reaching into every aspect of healthcare, blurring the boundaries between tech and medicine.

The revolution in gene and cell research continues to bring forward exciting new therapies.”

John Connolly
Life Sciences Industry Leader – North America, Willis Towers Watson

Digitalisation has accelerated, opening up opportunities in areas such as telemedicine and home care devices.

The revolution in gene and cell research continues to bring forward exciting new therapies, while the pandemic triggered the fastest vaccine approval in history.

Within this changing landscape new risks are emerging – from supply chain vulnerabilities to increased cyber and data threats – which have left insurance markets playing catch up.

This webinar looked at these and other trends shaping the sector’s future.

During this session, our experts covered:

  • The convergence of technology and medicine and what this means for insurance cover and liability, including latest case law
  • Why is product liability changing
  • How the rise of new medical technologies is increasing risks for companies
  • How technology is changing the way clinical trials are conducted
  • The ongoing rise of cell and gene therapies and how to mitigate the risks involved

Webinar recording

In case you missed it, the webnar recording can be accessed below:

Future proofing your life science business webinar recording

Webinar write up

We have also put together a review document providing an overview of the key talking points and learnings from the webinar, which can be downloaded from the link below:

Disclosure

Willis Towers Watson offers insurance-related services through its appropriately licensed and authorised companies in each country in which Willis Towers Watson operates. For further authorisation and regulatory details about our Willis Towers Watson legal entities, operating in your country, please refer to our Willis Towers Watson website. It is a regulatory requirement for us to consider our local licensing requirements.

Download

Title File Type File Size
Future proofing your life science business PDF .4 MB

Contact


John Connolly
North American Industry Leader - Life Sciences

Related content tags, list of links Webcast Direct and Facultative Life Sciences
Contact us